Section
Deals
Allegiant (ALGT) and Sun Country (SNCY) shareholders clear $1.5bn airline merger
Allegiant Travel and Sun Country Airlines holders separately approved the cash-and-stock merger and the related ALGT share issuance at special meetings on Friday, with closing expected May 13 and the combined leisure carrier set to operate about 195 aircraft across 650 routes.
BofA taps UBS tech dealmaker Hardegree as M&A vice chair
Bank of America has hired veteran technology banker Richard Hardegree from UBS as a vice chair of M&A, an internal memo shows, adding more than three decades of semiconductor dealmaking experience as global transaction volumes surge past $2 trillion in 2026.
Lilly, Gilead lead $64bn pharma M&A run as 2026 deal pace eclipses 2025
Pharma M&A struck 24 deals worth $64bn in upfront cash through April, well ahead of 2025's pace. Eli Lilly and Gilead Sciences lead the buying, with oncology and autoimmune assets soaking up most of the cash.
Kraken parent Payward to buy stablecoin payments firm Reap for $600m, deepens Asia push
Kraken's parent Payward agreed to buy Hong Kong-based stablecoin payments firm Reap Technologies for up to $600m in cash and stock at a $20bn valuation, its largest deal yet and a clear signal of the IPO pitch: financial infrastructure, not a spot exchange.
Eli Lilly prices $9bn eight-tranche bond, biggest-ever sale to fund $13bn M&A push
Eli Lilly priced $9bn of investment-grade bonds across eight tranches on Wednesday, its largest-ever debt sale, to fund the Centessa and Kelonia acquisitions. The 40-year tranche tightened 33 basis points from initial price talk to 80bp over Treasuries.
